Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher OpenFDA by Year
openFDA — Total FDA 510(k) Medical Device Clearances for the Danaher Ecosystem (Monthly / Quarterly / Annual)
Danaher OpenFDA: 20 in FY2025, down 35.5% from a year earlier.
Where the FY2025 figure comes from
Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Independent data from the openFDA database (updated monthly through 09/2026) measuring the pace of new diagnostic/medical device product launches by Danaher subsidiaries in the U.S. market.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up openFDA
- Beckman Coulter (Diagnostics & Life Sciences) — FDA 510(k) Clearances10 · FY2025
- Cepheid (GeneXpert Molecular Diagnostics) — FDA 510(k) Clearances6 · FY2025
- Radiometer Medical (Blood Gas & Acute Care Analyzers) — FDA 510(k) Clearances1 · FY2025
- Leica Biosystems & Microsystems (Pathology & Microscopy) — FDA 510(k) Clearances0 · FY2025
- HemoCue (Point-of-Care POC Hematology Testing) — FDA 510(k) Clearances0 · FY2025
- Devicor Medical / Mammotome (Breast Biopsy & Cancer Diagnostics) — FDA 510(k) Clearances0 · FY2025
- Masimo Corporation (Pulse Oximetry & Non-Invasive Patient Monitoring) — FDA 510(k) Clearances3 · FY2025
- U.S. Industry Benchmark — U.S. Industry Total 510(k) Clearances3,225 · FY2025
Cite this data
StockData. (2026). Danaher OpenFDA, annual FY2015–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-510k-dhr-total
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.